Timothy J Scialla, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9 Pinnacle Dr Ste A03, Fishersville, VA 22939 Phone: 844-472-8711 Fax: 434-243-7708 |
Dr. Carmen Laura Gonzalez, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 78 Medical Center Drive, Heart & Vascular Center, Flr 2, Fishersville, VA 22939 Phone: 540-245-7190 Fax: 540-245-7191 |
Dr. James Arthur Long, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 70 Medical Center Cir, Suite 307, Fishersville, VA 22939 Phone: 540-245-7190 Fax: 540-245-7191 |
News Archive
Higher summertime levels of outdoor ground-level ozone, microscopic particle pollution like smoke and smog, as well as other air pollutants may cause anyone who is sensitive to these airborne contaminants to experience shortness of breath, wheezing and coughing, and may also trigger asthma attacks and cause lung irritation.
Wearers of cochlear implants and hearing aids often have difficulty teasing out what someone is saying over "babble" - the cacophony of other talkers - and other ambient sounds. New York University researchers have devised a novel solution: an algorithmic approach that, like making drinkable water from pond water, distills the talker's voice from a turbid wash of noise.
In the first study to directly compare men and women with chronic obstructive pulmonary disease, or COPD, and severe emphysema, researchers have found that there are marked differences between the sexes.
In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.
› Verified 8 days ago